1. U.S. Department of Department of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research. Long term follow-up after administration of human gene therapy products: draft guidance for industry. https://www.fda.gov/ucm/groups/fdagov-public/@fdagov-bio-gen/documents/document/ucm610797.pdf (2018).
2. MIT NEWDIGS Initiative. FoCUS Project: financing of cures in the US. Research Brief 2017F211.v011. https://newdigs.mit.edu/sites/default/files/FoCUS_Research_Brief_2017F211v011.pdf (2017).
3. U.S. Food and Drug Administration. Expanded access. https://www.fda.gov/NewsEvents/PublicHealthFocus/ExpandedAccessCompassionateUse/default.htm (25 August 2017).
4. Caplan, A. & Moch, K. Rescue me: the challenge of compassionate use in the social media era. Health Affairs Blog https://www.healthaffairs.org/do/10.1377/hblog20140827.041027/full/ (2014).
5. Borysowski, J., Ehni, H. & Górski, A. BMC Med. 15, 136 (2017).